Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript

SA Transcripts159.12K FollowersFollow5ShareSaveCommentsQ4: 2026-03-25 Earnings SummaryInsightsTranscript InsightsPlay CallPlay CallEPS of -$0.10 misses by $0.01 | Revenue of $1.50M (25.65% Y/Y) beats by $143.80K Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call March 26, 2026 8:30 AM EDT Company Participants Matthew Riley - Director of Investor RelationsLishan Aklog - Chairman & CEODennis McGrath - Chief Financial Officer Conference Call Participants Mark Massaro - BTIG, LLC, Research DivisionKyle Mikson - Canaccord Genuity Corp., Research DivisionMichael Matson - Needham & Company, LLC, Research DivisionJeremy Pearlman - Maxim Group LLC, Research Division Presentation Operator Good morning, and welcome to the Lucid Diagnostics Fourth Quarter 2025 Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Matt Riley, Lucid Diagnostics' Vice President of Investor Relations. Please go ahead. Matthew RileyDirector of Investor Relations Thank you, operator, and good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics; along with Dennis McGrath, Chief Financial Officer. The press release announcing our business update and financial results is available on Lucid's website. Please take a moment to read the disclaimers about forward-looking statements in the press release. The business update, press release and conference call all include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the Securities and Exchange Commission. For a list and description of these and other important risk factors and uncertainties that may affect future operations, see Part 1, Item 1A entitled Risk Factors in Lucid's most recent annual report on Form 10-K filed with the SEC and any subsequent updates filed in quarterly reports on Forms 10-Q and subsequent